Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Urologic Neoplasms
×
enfortumab vedotin
×
Clear all
Filters
3
NCT03288545
2025-11-10
EV-103
Astellas Pharma Inc
Phase 1/2
Active not recruiting
348 enrolled
1 FDA
NCT03219333
2024-08-27
EV-201
Astellas Pharma Inc
Phase 2
Completed
219 enrolled
32 charts
2 FDA